Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies

Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies Age-related macular degeneration is the principal cause of registered legal blindness among those aged over 65 in the United States, western Europe, Australia, and Japan. Despite intensive research, the precise etiology of molecular events that underlie age-related macular degeneration is poorly understood. However, investigations on parallel fronts are addressing this prevalent public health problem. Sophisticated biochemical and biophysical techniques have refined our understanding of the pathobiology of drusen, geographic atrophy, and retinal pigment epithelial detachments. Epidemiological identification of risk factors has facilitated an intelligent search for underlying mechanisms and fueled clinical investigation of behavior modification. Gene searches have not only brought us to the cusp of identifying the culpable gene loci in age-related macular degeneration, but also localized genes responsible for other macular dystrophies. Recent and ongoing investigations, often cued by tumor biology, have revealed an important role for various growth factors, particularly in the neovascular form of the condition. Transgenic and knockout studies have provided important mechanistic insights into the development of choroidal neovascularization, the principal cause of vision loss in age-related macular degeneration. This in turn has culminated in preclinical and clinical trials of directed molecular interventions. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Survey of Ophthalmology Elsevier

Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies

Loading next page...
 
/lp/elsevier/age-related-macular-degeneration-etiology-pathogenesis-and-therapeutic-fakg2ojMVZ
Publisher
Elsevier
Copyright
Copyright © 2003 Elsevier Inc.
ISSN
0039-6257
D.O.I.
10.1016/S0039-6257(03)00030-4
Publisher site
See Article on Publisher Site

Abstract

Age-related macular degeneration is the principal cause of registered legal blindness among those aged over 65 in the United States, western Europe, Australia, and Japan. Despite intensive research, the precise etiology of molecular events that underlie age-related macular degeneration is poorly understood. However, investigations on parallel fronts are addressing this prevalent public health problem. Sophisticated biochemical and biophysical techniques have refined our understanding of the pathobiology of drusen, geographic atrophy, and retinal pigment epithelial detachments. Epidemiological identification of risk factors has facilitated an intelligent search for underlying mechanisms and fueled clinical investigation of behavior modification. Gene searches have not only brought us to the cusp of identifying the culpable gene loci in age-related macular degeneration, but also localized genes responsible for other macular dystrophies. Recent and ongoing investigations, often cued by tumor biology, have revealed an important role for various growth factors, particularly in the neovascular form of the condition. Transgenic and knockout studies have provided important mechanistic insights into the development of choroidal neovascularization, the principal cause of vision loss in age-related macular degeneration. This in turn has culminated in preclinical and clinical trials of directed molecular interventions.

Journal

Survey of OphthalmologyElsevier

Published: May 1, 2003

References

  • Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies
    Allikmets, R.; Seddon, J.M.; Bernstein, P.S.
  • Cyclic AMP elevating agents and nitric oxide modulate angiotensin II-induced leukocyte-endothelial cell interactions in vivo
    Alvarez, A.; Piqueras, L.; Blazquez, M.A.; Sanz, M.J.
  • Transscleral drug delivery to the retina and choroid
    Ambati, J.; Adamis, A.P.
  • A role for local inflammation in the formation of drusen in the aging eye
    Anderson, D.H.; Mullins, R.F.; Hageman, G.S.; Johnson, L.V.
  • Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation
    Anderson, D.H.; Ozaki, S.; Nealon, M.
  • Nitric oxide is proangiogenic in the retina and choroid
    Ando, A.; Yang, A.; Mori, K.
  • The role of oxidative stress in the pathogenesis of age-related macular degeneration
    Beatty, S.; Koh, H.; Phil, M.; Henson, D.; Boulton, M.
  • Cultured human retinal pigment epithelial cells differentially express thrombospondin-1, -2, -3, and -4
    Carron, J.A.; Hiscott, P.; Hagan, S.
  • Randomized trial of radiation for age-related macular degeneration
    Char, D.H.; Irvine, A.I.; Posner, M.D.
  • Prospective study of zinc intake and the risk of age-related macular degeneration
    Cho, E.; Stampfer, M.J.; Seddon, J.M.
  • Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
    Clauss, M.; Gerlach, M.; Gerlach, H.
  • Retinal sensitized photodynamic damage to liposomes
    Delmelle, M.
  • The carotenoids as anti-oxidants-a review
    Edge, R.; McGarvey, D.J.; Truscott, T.G.
  • Risk factors for age-related macular degeneration
    Evans, J.R.
  • Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
    Ferrara, N.; Henzel, W.J.
  • Age-related macular degeneration and choroidal neovascularization
    Freund, K.B.; Yannuzzi, L.A.; Sorenson, J.A.
  • The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration
    Friedman, E.
  • Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report (1)
    Fujii, G.Y.; Juan, E.; Pieramici, D.J.
  • Complications associated with limited macular translocation
    Fujii, G.Y.; Pieramici, D.J.; Humayun, M.S.
  • Photophysical studies on human retinal lipofuscin
    Gaillard, E.R.; Atherton, S.J.; Eldred, G.; Dillon, J.
  • In vivo use of oligonucleotides to inhibit choroidal neovascularisation in the eye
    Garrett, K.L.; Shen, W.Y.; Rakoczy, P.E.
  • Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes
    Gilbert, R.E.; Kelly, D.J.; Cox, A.J.
  • Translocation of the macula for management of subfoveal choroidal neovascularization: comparison of results in age-related macular degeneration and degenerative myopia
    Glacet-Bernard, A.; Simon, P.; Hamelin, N.
  • The expression of heat shock protein 70 decreases with cellular senescence in vitro and in cells derived from young and old human subjects
    Gutsmann-Conrad, A.; Heydari, A.R.; You, S.; Richardson, A.
  • An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the rpe-bruch's membrane interface in aging and age-related macular degeneration
    Hageman, G.S.; Luthert, P.J.; Victor Chong, N.H.
  • Alu DNA polymorphism in ACE gene is protective for age-related macular degeneration
    Hamdi, H.K.; Reznik, J.; Castellon, R.
  • Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study
    Heiba, I.M.; Elston, R.C.; Klein, B.E.; Klein, R.
  • Inhibitory effect of losartan on laser-induced choroidal neovascularization in rats
    Hikichi, T.; Mori, F.; Takamiya, A.
  • Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration
    Holekamp, N.M.; Bouck, N.; Volpert, O.
  • Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration
    Holz, F.G.; Bellman, C.; Staudt, S.
  • Pigment epithelium-derived factor exerts opposite effects on endothelial cells of different phenotypes
    Hutchings, H.; Maitre-Boube, M.; Tombran-Tink, J.; Plouet, J.
  • Expression of matrix metalloproteinase-7 in choroidal neovascular membranes in age-related macular degeneration
    Kadonosono, K.; Yazama, F.; Itoh, N.
  • Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration
    Kimura, K.; Isashiki, Y.; Sonoda, S.
  • Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study
    Lewis, H.; Kaiser, P.K.; Lewis, S.; Estafanous, M.
  • Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization
    Mori, K.; Duh, E.; Gehlbach, P.
  • Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells
    Mousa, S.A.; Lorelli, W.; Campochiaro, P.A.
  • Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF
    Ohno-Matsui, K.; Morita, I.; Tombran-Tink, J.
  • Advanced glycation end products induce angiogenesis in vivo
    Okamoto, T.; Tanaka, S.; Stan, A.C.
  • Zinc, total protein, and albumin in CSF of patients with cerebrovascular diseases
    Palm, R.; Strand, T.; Hallmans, G.
  • Immunological and aetiological aspects of macular degeneration
    Penfold, P.L.; Madigan, M.C.; Gillies, M.C.; Provis, J.M.
  • Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration
    Penfold, P.L.; Wen, L.; Madigan, M.C.
  • Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration
    Pieramici, D.J.; De Juan, E.; Fujii, G.Y.
  • Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration
    Rodanant, N.; Friberg, T.R.; Cheng, L.
  • Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age-related macular degeneration
    Ross, R.D.; Barofsky, J.M.; Cohen, G.
  • The e4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration
    Souied, E.H.; Benlian, P.; Amouyel, P.
  • Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells
    Takahashi, T.; Nakamura, T.; Hayashi, A.
  • The relation of coffee and caffeine to the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study
    Tomany, S.C.; Klein, R.; Klein, B.E.
  • Direct measurement of VEGF-induced nitric oxide production by choroidal endothelial cells
    Uhlmann, S.; Friedrichs, U.; Eichler, W.
  • Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
    Unemori, E.N.; Ferrara, N.; Bauer, E.A.; Amento, E.P.
  • A 5-year follow-up study for distance visual acuity after low dose radiation on subfoveal choroidal neovascularization in age-related macular degeneration
    Valmaggia, C.; Ries, G.; Ballinari, P.
  • Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions
    Weeks, D.E.; Conley, Y.P.; Tsai, H.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off